Ampio Pharmaceuticals (NYSE:AMPE) Now Covered by StockNews.com

Analysts at StockNews.com started coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued to clients and investors on Thursday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Ampio Pharmaceuticals stock opened at $0.00 on Thursday. The firm has a 50 day simple moving average of $0.01 and a 200-day simple moving average of $0.01. Ampio Pharmaceuticals has a 1-year low of $0.00 and a 1-year high of $2.47. The stock has a market cap of $681.00, a price-to-earnings ratio of 0.00 and a beta of 3.66.

Ampio Pharmaceuticals Company Profile

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.